• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UNKNOWN CENTRAL VASCULAR CATHETER; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UNKNOWN CENTRAL VASCULAR CATHETER; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Device Problems Obstruction of Flow (2423); Appropriate Term/Code Not Available (3191)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Fresenius became aware through a survey that this peritoneal dialysis (pd) patient on continuous cyclic pd (ccpd) therapy on the liberty select cycler underwent surgery following a transition from pd to hemodialysis (hd) for renal replacement therapy.There was no specific allegation this event was related to a deficiency or malfunction of any fresenius device(s) or product(s) in the initial reporting.Upon follow up with the patient's pd registered nurse, it was reported this patient was transitioned from pd to hd for renal replacement therapy per physician direction following bariatric surgery.Along the course of in-center hd therapy, the patient's central vascular catheter (not a fresenius product) was found to be obstructed by a clot that could not be cleared in the dialysis clinic (exact date unknown).The patient underwent an outpatient nonemergent central vascular catheter exchange on (b)(6) 2021.It was confirmed the patient did not experience a serious injury or adverse event as a result of the obstructed central vascular catheter.Additionally, it was affirmed the obstructed central vascular catheter and the associated procedure were not due to a deficiency or malfunction of any fresenius product(s) or device(s).The patient continued in-center hd therapy following this event.The patient had their pd catheter replaced and resumed ccpd therapy on the same liberty select cycler in (b)(6) 2021.Based on the required information, there is no indication of a serious injury, patient death, or other adverse event related to a fresenius product or other issue.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTRAL VASCULAR CATHETER
Type of Device
CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
UNKNOWN
MDR Report Key17524626
MDR Text Key321409271
Report NumberMW5131572
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 06/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/12/2023
Patient Sequence Number1
-
-